Xelleratherapeutics · Newsroom

Current Good Manufacturing Practice: Strengthening Quality and Trust in Modern Manufacturing
Current Good Manufacturing Practice (cGMP) ensures product quality, safety, and consistency through regulated manufacturing standards, validation, documentation, and compliance.

December 19, 2025

Strengthening IP Protection to Safeguard Innovation in a Rapidly Evolving Global Market
Strengthening IP protection is crucial in a fast-evolving global market. Robust safeguards help prevent infringement, protect proprietary innovations, support fair competition.

November 25, 2025

Advancing Precision in Drug Development: The Growing Importance of Bioanalytical Testing
Discover how bioanalytical testing is revolutionizing drug development by ensuring precision, safety, and regulatory compliance from research to commercialization.

October 17, 2025

Ensuring Quality and Safety: cGMP Standards Drive Excellence in Pharmaceutical Manufacturing
Current Good Manufacturing Practices (cGMP) set strict global standards to ensure pharmaceutical products are consistently safe, effective, and high quality.

September 25, 2025

Xellera Therapeutics Enhances Quality Control Capabilities to Strengthen Regulatory Compliance and Product Integrity
Quality control ensures the safety, consistency, and compliance of products through rigorous testing and validation at every stage of development and manufacturing.

June 25, 2025